chemical:semaglutide
After two months, Novo Nordisk and HIMS part ways
Novo Nordisk and HIMS end their partnership that brought cheaper Wegovy (Semaglutide) to customers of HIMS.
chemical:semaglutide
Novo Nordisk and HIMS end their partnership that brought cheaper Wegovy (Semaglutide) to customers of HIMS.
category:news
We deep dive on Bimagrumab, a muscle-preserving booster to GLP1 receptor agonists like Ozempic, Wegovy, Mounjaro, Zepbound and others.
company:novo-nordisk
Novo Nordisk's patent protections lapse early after forgetting to pay a small fee allows a Canadian Generic to get to market faster.
research
Finally, a research clinical trial that directly explores the difference between Semaglutide and Tirzepatide for Obesity.
malady:addiction
We trace research on GLP1s and addiction through the years and try to find studies that match the anecdotes.
research
Walk farther with GLP1s -- results from the STRIDE study show Semaglutide effective for treating Peripheral Artery Disease (PAD)
company:novo-nordisk
Novo Nordisk makes available cheaper Wegovy, via it's savings plan, purchasable at local pharmacies.
chemical:semaglutide
It happened sooner than we expected -- the FDA has announced Semaglutide shortage resolution, removing it from the shortage list.
category:news
HIMS leans into Liraglutide as a replacement for Semaglutide in the face of shortage rule changes. Is it good enough?
chemical:semaglutide
Semaglutide and Liraglutide continue to be researched and studied and produce positive results for weight loss and medical outcomes.
category:side-effects
We explore the link between blinding disease/vision loss and Semaglutide, as reported by medical research.
category:factsheet
How long will we have to wait for generic versions of GLP1 drugs? We take a look at patent expiry dates for the most popular brands & GLP1 formulations.